26285-1-AP

antibody from Proteintech Group

Targeting: TRIM7 GNIP, RNF90

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

26285-1-AP

Provider

Proteintech Group

Product name

TRIM7 antibody

Antibody type

Polyclonal

Description

TRIM7 antibody (Cat. #26285-1-AP) is a rabbit polyclonal antibody that shows reactivity with mouse and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Mouse

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

Columbianadin targets TRIM7 to maintain P2X7 palmitoylation, inhibiting cuproptosis in synovial M2 macrophages.

Li Z, Huang Z, Liao X, Li H
Phytomedicine : international journal of phytotherapy and phytopharmacology 2025 Oct;146:157091

---

Trim7 aggravates ischemic stroke-associated ferroptosis by promoting ubiquitin-mediated degradation of HSPA5.

Lu W, Hu S, Zhang W, Wang R, Zhao D, Ji P, Zhang P, Zhang Y, Gao H, Wang Z, Li T, Lu Z, Li Z
Cell & bioscience 2025 Oct 22;15(1):142

---

TRIM7 suppresses transmissible gastroenteritis virus replication by targeting the degradation of N protein and activating RIG-I-mediated type I IFN antiviral response.

Qin W, Xie Y, Liang H, Wu Z, Yang S, Zhou X, Zhao A
Veterinary research 2025 Nov 5;56(1):210

---

E3 Ubiquitin Ligase TRIM7 Alleviates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.

Wang Y, Xu X, Zhang P, Hu S, Zhang L, Chen H
The American journal of pathology 2025 Apr;195(4):639-651

---

Transcriptomic analysis reveals transcription factors implicated in radon-induced lung carcinogenesis.

Liu X, Peng Y, Chen R, Zhou Y, Zou X, Xia M, Wu X, Yu M
Toxicology research 2024 Oct;13(5):tfae161

---

The E3 ligase TRIM7 suppresses the tumorigenesis of gastric cancer by targeting SLC7A11.

Chen Q, Zhang T, Zeng R, Zhang K, Li B, Zhu Z, Ma X, Zhang Y, Li L, Zhu J, Zhang G
Scientific reports 2024 Mar 20;14(1):6655

---

The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.

Fan L, Zhou Y, Wei X, Feng W, Guo H, Li Y, Gao X, Zhou J, Wen Y, Wu Y, Shen X, Liu L, Xu G, Zhang Z
mBio 2024 Feb 14;15(2):e0232023

---

TRIM7 inhibits encephalomyocarditis virus replication by activating interferon-β signaling pathway.

Li M, Yan J, Zhu H, Guo C, Jiang X, Gao Y, Liu X, Jiang P, Bai J
Veterinary microbiology 2023 Jun;281:109729

---

N6-Methyladenosine modification of the TRIM7 positively regulates tumorigenesis and chemoresistance in osteosarcoma through ubiquitination of BRMS1.

Zhou C, Zhang Z, Zhu X, Qian G, Zhou Y, Sun Y, Yu W, Wang J, Lu H, Lin F, Shen Z, Zheng S
EBioMedicine 2020 Sep;59:102955

---

Nascent Transcriptomics Reveal Cellular Prolytic Factors Upregulated Upstream of the Latent-to-Lytic Switch Protein of Epstein-Barr Virus.

Frey TR, Brathwaite J, Li X, Burgula S, Akinyemi IA, Agarwal S, Burton EM, Ljungman M, McIntosh MT, Bhaduri-McIntosh S
Journal of virology 2020 Mar 17;94(7)